Transplant drug may ease disorder linked to autism

Todd Fugere's picture

A DRUG that prevents immune rejection in human transplant patients has improved the memory of mice with a hereditary learning disorder. The finding suggests the disorder is a result of reversible abnormalities in brain chemistry rather than irreversible differences in architecture, as was previously assumed.

author: 
New Scientist